Skip to content

Intervertebral Disc Augmentation With Minimally Invasive Surgical Procedure

Intervertebral Disc Nucleus Augmentation With Allograft Meniscus With Minimally Invasive Surgical Procedure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01442922
Enrollment
1
Registered
2011-09-29
Start date
2011-03-31
Completion date
2012-12-31
Last updated
2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease

Keywords

L3-L4, L4-L5, L5-S1, Human Meniscus Allograft, Nucleus pulposus, Minimally invasive surgery, Degeneration of L3-L4 Intervertebral Disc, Degeneration of L4-L5 Intervertebral Disc, Degeneration of L5-S1 Intervertebral Disc

Brief summary

The primary purpose of the study is to establish the degree and duration of pain relief following minimally invasive surgery for a painful degenerative disc.

Detailed description

The investigators will study patient recovery (outcome measures) in patients who have had minimally invasive surgery for implantation of human meniscus allograft (HMA) to replace the nucleus pulposus of a degenerative intervertebral disc.

Interventions

OTHERcompletion of the (VAS) for level of back pain

Patients will complete the (VAS) pre-operatively and post-operatively at 6 wks, and 3, 6, 12, and 24 mos.

OTHERcompletion of the (OLBPQ) for assessment of function

Patients will complete the (OLBPQ) pre-operatively and post-operatively at 6 wks, and 3, 6, 12, and 24 mos.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of degenerative disk disease at L3-L4, L4-L5, or L5-S1 * low back for no more that one year prior to enrollment

Exclusion criteria

* Osteoporosis * Degenerative changes of vertebral endplates (obvious fractures, osteophytes) * Modic Type II changes indicative of advanced bony degeneration * Facet arthrosis (loss of facet joint cartilage, increased synovial fluid collection, or presence of osteophytes in inferior or superior plates) * Discs classified with stage I or II degeneration * Patients unable to have an MRI (pacemaker, claustrophobia, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS) documentation of the level of back pain. The (VAS) will describe the change in the level of back pain from the pre-op level.Patients will complete the (VAS) at pre-op and at 6 wks. and at 3, 6, 12, and 24 mos. post-operatively.Patients will complete the (VAS) pre-operatively and post-operatively at 6 wks, and 3, 6, 12, and 24 mos. Responses are expressed on a ten centimeter line, with 0 representing no pain and 10cm representing the worst pain possible. The patient places a mark across the line representing where their perceived pain lies, from no pain to severe pain.

Secondary

MeasureTime frameDescription
The Oswestry Low Back Pain Disability Questionnaire (OLBPQ) function assessment The (OLBPQ) will describe the change in the level of function from the pre-op level.Patients will complete the (OLBPQ) at pre-op and at 6 wks. and at 3, 6, 12, and 24 mos. post-operatively.Patients will complete the (OLBPQ) pre-operatively and post-operatively at 6 wks, and 3, 6, 12, and 24 mos. This is a 10-question self-rating scale used to evaluate the degree of functional impairment a patient is experiencing in a number of activities of daily living.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026